SCHEMBL787100

SCHEMBL787100

CC(C)(C)NC(=S)NCCCCC(=O)N1CCC2CCCC=C2C1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 2/20 0.34
HTT P42858 1/20 0.34
NAMPT P43490 3/20 0.33
QPCT Q16769 1/20 0.32
BCHE P06276 1/20 0.32
ACHE P22303 1/20 0.32
KEAP1 Q14145 2/20 0.32
NFE2L2 Q16236 2/20 0.32
DPP4 P27487 2/20 0.32
KMT2A Q03164 2/20 0.31
POLB P06746 1/20 0.31
NPC1 O15118 1/20 0.31
ALDH1A1 P00352 1/20 0.31
CYP2D6 P10635 1/20 0.31
CYP2C9 P11712 1/20 0.31
CYP2C19 P33261 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
ADAMTS4 O75173 1/20 0.31
ADAMTS5 Q9UNA0 1/20 0.31
KCNH2 Q12809 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL770590 0.87 HTT (0.37) RAB9AHTTKMT2APOLBALDH1A1
SCHEMBL772452 0.85 KMT2A (0.40) RAB9AQPCTKMT2ANPC1LMNA
SCHEMBL771786 0.84 KMT2A (0.41) RAB9AQPCTKMT2ANPC1LMNA
SCHEMBL771107 0.83 ADAMTS4 (0.36) NAMPTKMT2AADAMTS4ADAMTS5
SCHEMBL770013 0.83 ALDH1A1 (0.43) RAB9AHTTNAMPTKMT2ANPC1
SCHEMBL15377462 0.83 EPHX2 (0.49) ALDH1A1
SCHEMBL15377565 0.82 ALDH1A1 (0.44) RAB9AHTTKMT2ANPC1ALDH1A1
SCHEMBL770401 0.82 LMNA (0.39) HTTNAMPTKMT2ANPC1ALDH1A1
SCHEMBL770861 0.81 EPHX1 (0.38) NAMPTBCHEACHEKMT2ANPC1
SCHEMBL771041 0.81 KDM1A (0.44) HTTALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8822452-B2 Inhibitor compounds of 11-beta-hydroxysteroid dehydrogenase type 1 LABORATORIOS SALVAT, S.A. (ES) 2014-09-02 US disclosed
US-20130303522-A1 INHIBITOR COMPOUNDS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 LABORATORIOS SALVAT, S.A. (ES) 2013-11-14 US disclosed
US-8524894-B2 Inhibitor compounds of 11-beta-hydroxysteroid dehydrogenase type 1 LABORATORIOS SALVAT, S.A. (ES) 2013-09-03 US disclosed
US-20120071466-A1 INHIBITOR COMPOUNDS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 LABORATORIOS SALVAT, S.A. (ES) 2012-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130303522-A1 INHIBITOR COMPOUNDS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 HSD11B1, HSD17B1, HSD11B2 RAB9A 2187/4885HTT 412/4885NAMPT 2501/4885
US-20120071466-A1 INHIBITOR COMPOUNDS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 HSD11B1, HSD17B1, HSD11B2 RAB9A 2217/4885HTT 425/4885NAMPT 2543/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.